From Holdens to hematopoietic stem cell expansion: meet the investor taking Australian manufacturing way up the value chain
A company that can turn old newspapers into pharmaceutical-grade solvent is among the investees of…
Manifex is an evergreen private investment firm established in 2014 to manage pooled investments by knowledgeable investors in a targeted portfolio of new ventures.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Proin nibh augue, suscipit a, scelerisque.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Proin nibh augue, suscipit a, scelerisque.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Proin nibh augue, suscipit a, scelerisque.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Proin nibh augue, suscipit a, scelerisque.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Proin nibh augue, suscipit a, scelerisque.
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Proin nibh augue, suscipit a, scelerisque.
Manifex Pty Ltd has a versatile structure to support early returns to shareholders and opportunities for reinvestment.
Manifex operates very closely (is co-located) with VCAMM and related research institutes. This provides opportunity to assess opportunities that are being pre-qualified and supported to ‘investible’ state by the institutions.
Manifex operates with a lean management philosophy which provides ability to manage investment capital tranches appropriate to the business needs at the time.
It also operates on a low management overhead, leveraging the expertise and business networks of the company board.
Chairman
TK has served as Chairman of Manifex since Oct 2014. He is currently the Managing Director of 1WORLD Telecommunications, founded in 1999. 1World is a telecommunications corporation, specialising in the Asia Pacific market. TK plays an integral role in the Technical Development of 1WORLD’s new products and its Sales and Market Development divisions. He also…
Director
Stuart trained in medicine and surgery. Founded and co-founded multiple technology companies to commercialise medical devices he had designed, in both Australia and Hong Kong. His executive role was as a director and also as the head of R&D. Has been instrumental in the trade sale of four of these companies to large multinationals over…
Managing Director
With a background in a variety of industry and consulting roles, Iain has been responsible for business process improvement, general management, business development, product development, manufacturing and management of R&D portfolios. He has a solid understanding and passion for business, entrepreneurship and the management of innovation as the foundation for building viable, profitable manufacturing enterprises….
Strategic Advisor
Dr. Donovan is currently working on a range of development projects within ASEAN, conducting capacity building with government partners and technical assistance with the private sector aimed at improving the impact of foreign investment on development within the region and SME competitiveness. This include with the Philippines Board of Investments, Lao Ministry of Planning and Investment, Thailand Board of Investment, Myanmar Directorate for Investment and Company Administration and the Indonesian National Development Planning Agency. He has also been a Program Leader of SME Engagement, Education and Innovation Management within the Advanced Manufacturing Cooperative Research Centre.
Strategic Advisor
Dr. Masli has extensive business and advisory experience in fund raising for corporations in the Southeast Asia region. He has worked as an investment banker in Thailand, Indonesia and Singapore, concluded major deals including leading the initial public offerings (IPO) of major corporations, advising mergers and acquisitions (M&A) for multinationals, and raising funds via syndicated loans for local companies. At the moment, Dr. Masli is providing advice on policy formation and data analytics projects for the Ministry of Planning and Investment in Lao PDR. He is also Principal Advisor-Technology Entrepreneurship and Commercialization Developmentto the National Agency for Technology Entrepreneurship and Commercialization (NATEC) of the Ministry of Science and Technology, Republic of Vietnam, to support NATEC-associated initiatives to develop the start-up and innovation eco-system of Vietnam.
Manifex currently has two exciting investments in the portfolio. Cytomatrix is a biotech firm with stem cell therapeutic blood product. Circa Group is a ‘green chemicals’ firm.
A company that can turn old newspapers into pharmaceutical-grade solvent is among the investees of…
Evergreen private investment firm Manifex has announced the opening of its second round of investment…
0409 141 769